GlassScriptPhysician profile
Steven P Wittmer
NPI 1104820869
$8,644.78
in general payments reported to CMS, 2019-2025
48 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $1,362 · 2021: $1,975 · 2022: $1,070 · 2023: $789 · 2024: $914 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,838.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,240.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $689.91 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $684.96 | 2019-2024 | |
| Abbvie INC. | $653.20 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $507.19 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $490.05 | 2019-2023 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $418.30 | 2019-2022 | |
| Glaxosmithkline, LLC. | $364.88 | 2019-2025 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $320.49 | 2019-2022 | |
| Exact Sciences Corporation | $316.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Allergan, INC. | $264.18 | 2019-2020 | |
| Astellas Pharma US INC | $255.85 | 2019-2020 | |
| Amgen INC. | $248.17 | 2019-2025 | Evenity, Prolia, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $243.34 | 2021-2025 | |
| Abbott Laboratories | $191.95 | 2021-2023 | Freestyle Libre 2 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wittmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.